AR005197A1 - Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen - Google Patents

Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen

Info

Publication number
AR005197A1
AR005197A1 ARP960105851A ARP960105851A AR005197A1 AR 005197 A1 AR005197 A1 AR 005197A1 AR P960105851 A ARP960105851 A AR P960105851A AR P960105851 A ARP960105851 A AR P960105851A AR 005197 A1 AR005197 A1 AR 005197A1
Authority
AR
Argentina
Prior art keywords
preparation
pharmaceutical compositions
taxoids
derivatives
contain
Prior art date
Application number
ARP960105851A
Other languages
English (en)
Spanish (es)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR005197A1 publication Critical patent/AR005197A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP960105851A 1995-12-22 1996-12-20 Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen AR005197A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515379A FR2742751B1 (fr) 1995-12-22 1995-12-22 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
AR005197A1 true AR005197A1 (es) 1999-04-14

Family

ID=9485871

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105851A AR005197A1 (es) 1995-12-22 1996-12-20 Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen

Country Status (40)

Country Link
US (1) US5728849A (forum.php)
EP (1) EP0876362B1 (forum.php)
JP (1) JP3953106B2 (forum.php)
KR (1) KR100500351B1 (forum.php)
CN (1) CN1103766C (forum.php)
AR (1) AR005197A1 (forum.php)
AT (1) ATE250593T1 (forum.php)
AU (1) AU712597B2 (forum.php)
BG (1) BG63204B1 (forum.php)
BR (1) BR9612135A (forum.php)
CA (1) CA2238884C (forum.php)
CO (1) CO4520184A1 (forum.php)
CZ (1) CZ294972B6 (forum.php)
DE (1) DE69630145T2 (forum.php)
DK (1) DK0876362T3 (forum.php)
DZ (1) DZ2149A1 (forum.php)
EA (1) EA001533B1 (forum.php)
ES (1) ES2202490T3 (forum.php)
FR (1) FR2742751B1 (forum.php)
HU (1) HU225032B1 (forum.php)
IL (1) IL124994A (forum.php)
IN (4) IN186768B (forum.php)
MA (1) MA26412A1 (forum.php)
MX (1) MX9804688A (forum.php)
MY (1) MY113934A (forum.php)
NO (1) NO317358B1 (forum.php)
NZ (1) NZ324337A (forum.php)
OA (1) OA10700A (forum.php)
PE (1) PE25198A1 (forum.php)
PL (1) PL189311B1 (forum.php)
PT (1) PT876362E (forum.php)
RO (1) RO116194B1 (forum.php)
SK (1) SK282835B6 (forum.php)
TN (1) TNSN96169A1 (forum.php)
TR (1) TR199801179T2 (forum.php)
TW (1) TW371659B (forum.php)
UA (1) UA48205C2 (forum.php)
UY (1) UY24386A1 (forum.php)
WO (1) WO1997023473A1 (forum.php)
ZA (1) ZA9610737B (forum.php)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
TR200102855T1 (tr) 2000-02-02 2002-06-21 Florida State University Research Foundation, Inc Antitümör ajanları olarak C10 karbonat ikameli taksanlar.
PT1368349E (pt) * 2001-02-24 2007-04-30 Boehringer Ingelheim Pharma Derivados de xantina, sua preparação e sua utilização como medicamento
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
AU2003239511A1 (en) * 2003-05-20 2004-12-13 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
EP1669358A1 (en) * 2004-12-07 2006-06-14 Aventis Pharma S.A. Cytotoxic agents comprising new taxanes
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
MX2008014024A (es) 2006-05-04 2008-11-14 Boehringer Ingelheim Int Formas poliformas.
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
ES2733348T3 (es) * 2007-08-17 2019-11-28 Boehringer Ingelheim Int Derivados de purina para uso en el tratamiento de enfermedades relacionadas con FAP
PE20140960A1 (es) 2008-04-03 2014-08-15 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
BRPI0916997A2 (pt) 2008-08-06 2020-12-15 Boehringer Ingelheim International Gmbh Inibidor de dpp-4 e seu uso
EP2326326B1 (en) * 2008-08-15 2019-10-09 Boehringer Ingelheim International GmbH Dpp-4 inhibitors for use for the treatment of wound healing in diabetic patients
WO2010029089A2 (en) 2008-09-10 2010-03-18 Boehringer Ingelheim International Gmbh Combination therapy for the treatment of diabetes and related conditions
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
EP2382216A1 (en) 2008-12-23 2011-11-02 Boehringer Ingelheim International GmbH Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
EP2504002B1 (en) 2009-11-27 2019-10-09 Boehringer Ingelheim International GmbH Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
PT2566469T (pt) 2010-05-05 2023-01-10 Boehringer Ingelheim Int Terapia de combinação
JP5843855B2 (ja) 2010-06-24 2016-01-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病療法
AR083878A1 (es) 2010-11-15 2013-03-27 Boehringer Ingelheim Int Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
DK2731947T3 (en) 2011-07-15 2019-04-23 Boehringer Ingelheim Int SUBSTITUTED DIMERIC QUINAZOLINE DERIVATIVE, PREPARATION AND USE thereof IN PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF TYPE I AND TYPE II DIABETES
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849754B1 (en) 2012-05-14 2022-09-14 Boehringer Ingelheim International GmbH Linagliptin, a xanthine derivative as dpp-4 inhibitor, for use in the treatment of sirs and/or sepsis
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2014080251A1 (en) 2012-11-24 2014-05-30 Hangzhou Dac Biotech Co., Ltd. Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
FR3010839B1 (fr) * 2013-09-17 2017-04-21 Schneider Electric Ind Sas Dispositif de raccordement electrique d'au moins un conducteur dans une borne appartenant a un appareil electrique
WO2015128453A1 (en) 2014-02-28 2015-09-03 Boehringer Ingelheim International Gmbh Medical use of a dpp-4 inhibitor
EP3122757B1 (en) 2014-02-28 2023-09-06 Hangzhou Dac Biotech Co., Ltd Charged linkers and their uses for conjugation
AU2015242213A1 (en) 2015-07-12 2018-03-08 Hangzhou Dac Biotech Co., Ltd Bridge linkers for conjugation of cell-binding molecules
US9839687B2 (en) 2015-07-15 2017-12-12 Suzhou M-Conj Biotech Co., Ltd. Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合
NZ752394A (en) 2016-11-14 2021-07-30 Hangzhou Dac Biotech Co Ltd Conjugation linkers, cell binding molecule-drug conjugates containing the likers, methods of making and uses such conjugates with the linkers
WO2022078524A2 (en) 2021-11-03 2022-04-21 Hangzhou Dac Biotech Co., Ltd. Specific conjugation of an antibody

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017724C1 (ru) * 1990-07-12 1994-08-15 Дзе Юниверсити оф Канзас Способ получения производных таксола
US5059699A (en) * 1990-08-28 1991-10-22 Virginia Tech Intellectual Properties, Inc. Water soluble derivatives of taxol
FR2678930B1 (fr) * 1991-07-10 1995-01-13 Rhone Poulenc Rorer Sa Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii.
RU2059631C1 (ru) * 1991-11-29 1996-05-10 Дзе Юниверсити оф Канзас Производные таксола и фармацевтическая композиция, обладающая противоопухолевой активностью
DE69325454T2 (de) * 1992-04-17 2000-01-20 Abbott Laboratories, Abbott Park Taxol-derivate
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
MX9307777A (es) * 1992-12-15 1994-07-29 Upjohn Co 7-HALO-Y 7ß, 8ß-METANO-TAXOLES, USO ANTINEOPLASTICO Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN.

Also Published As

Publication number Publication date
FR2742751A1 (fr) 1997-06-27
MX9804688A (es) 1998-10-31
EP0876362B1 (fr) 2003-09-24
IN188469B (forum.php) 2002-09-28
DE69630145T2 (de) 2004-07-15
ES2202490T3 (es) 2004-04-01
BG63204B1 (bg) 2001-06-29
CA2238884A1 (fr) 1997-07-03
IN186768B (forum.php) 2001-11-03
PL327405A1 (en) 1998-12-07
NZ324337A (en) 2000-03-27
PL189311B1 (pl) 2005-07-29
CZ196198A3 (cs) 1998-09-16
MY113934A (en) 2002-06-29
DK0876362T3 (da) 2004-02-02
NO982580D0 (no) 1998-06-05
IL124994A (en) 2000-12-06
JP3953106B2 (ja) 2007-08-08
DZ2149A1 (fr) 2002-10-23
BG102569A (en) 1999-04-30
KR19990076680A (ko) 1999-10-15
TNSN96169A1 (fr) 2005-03-15
OA10700A (fr) 2002-11-27
HK1017895A1 (en) 1999-12-03
CA2238884C (fr) 2007-02-06
TR199801179T2 (xx) 1998-10-21
NO982580L (no) 1998-06-05
AU1180997A (en) 1997-07-17
HUP9904046A1 (hu) 2001-04-28
MA26412A1 (fr) 2004-12-20
IL124994A0 (en) 1999-01-26
TW371659B (en) 1999-10-11
HUP9904046A3 (en) 2001-08-28
EP0876362A1 (fr) 1998-11-11
KR100500351B1 (ko) 2005-12-21
CN1205697A (zh) 1999-01-20
IN188680B (forum.php) 2002-10-26
BR9612135A (pt) 1999-07-13
IN188470B (forum.php) 2002-09-28
JP2000502671A (ja) 2000-03-07
PE25198A1 (es) 1998-05-10
CO4520184A1 (es) 1997-10-15
HU225032B1 (en) 2006-05-29
AU712597B2 (en) 1999-11-11
NO317358B1 (no) 2004-10-18
DE69630145D1 (de) 2003-10-30
US5728849A (en) 1998-03-17
WO1997023473A1 (fr) 1997-07-03
RO116194B1 (ro) 2000-11-30
PT876362E (pt) 2004-02-27
ATE250593T1 (de) 2003-10-15
UA48205C2 (uk) 2002-08-15
SK85398A3 (en) 1998-11-04
FR2742751B1 (fr) 1998-01-30
CZ294972B6 (cs) 2005-04-13
CN1103766C (zh) 2003-03-26
EA001533B1 (ru) 2001-04-23
UY24386A1 (es) 2001-08-27
EA199800588A1 (ru) 1998-12-24
SK282835B6 (sk) 2002-12-03
ZA9610737B (en) 1997-06-27

Similar Documents

Publication Publication Date Title
AR005197A1 (es) Derivados de taxoides, su preparacion y composiciones farmaceuticas que los contienen
AR001440A1 (es) Nuevos taxoides, su preparación y composiciones farmacéuticas que los contienen.
YU68792A (sh) Postupak za dobivanje derivata bakatina iii i 10-dezacetil-bakatina iii
ES2152414T3 (es) Dihidrobenzofuranos.
FR2657526B1 (fr) Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
HUP0004592A2 (hu) VCAM-1 expresszió gátlására alkalmas vegyületek és eljárások
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
DE68901162D1 (de) Ungesaettigte derivate fettloeslicher benzalmalonate und ihre verwendung als uv-absorber in der kosmetik.
ATE168685T1 (de) Aminoheterocyclische derivate als antithrombotische oder antikoagulierende mittel
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
MX9301986A (es) Derivados de perhidroisoindol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
DE3865353D1 (de) Neue makromolekulare, oberflaechenaktive, quaternaere, n-substituierte chitosanderivate sowie kosmetisches mittel auf der basis dieser neuen chitosanderivate.
YU89791A (sh) Postupak za dobijanje enantioselektivnih derivata fenilizoserina
ES2101513T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
FR2682381B1 (fr) Derives de benzodiazepine, leur preparation et les medicaments les contenant.
ES2148758T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
ATE242230T1 (de) Chroman derivate
FI930171A0 (fi) Piperidinfoereningar, framstaellning och anvaendning av dessa
ATE75226T1 (de) Substituierte triazinderivate.
NO971142L (no) Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler
ES2121395T3 (es) Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
HUP9803028A2 (hu) Ciklusos nitronok és az azokat hatóanyagként tartalmazó gyógyszerkészítmények
MX25747A (es) 3'-desamino-4' -desoxi-4' -amino-8-fluoroantraciclinas y procedimiento para su preparacion.
DE3370619D1 (de) Indole derivatives
ES2162126T3 (es) Nuevos taxoides, su preparacion y las composiciones farmaceuticas que les contienen.

Legal Events

Date Code Title Description
FG Grant, registration